 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: TYSABRI (natalizumab) |
|
***************************************************** |
|
#Post#: 2716-------------------------------------------------- |
|
(Abst.) Developing a model of care for home infusions of Tysabri |
|
... |
|
By: agate Date: November 8, 2019, 12:48 pm |
|
--------------------------------------------------------- |
|
Some nursing researchers are studying developing a way to make |
|
home infusions of Tysabri possible for people with MS.From |
|
PubMed, November 8, 2019--"Developing a Model of Care for Home |
|
Infusions of Natalizumab for people with Multiple Sclerosis": |
|
https://www.ncbi.nlm.nih.gov/pubmed/31693562 |
|
#Post#: 3355-------------------------------------------------- |
|
(Abst.) Home Tysabri infusions...a pilot randomized cross-over t |
|
rial |
|
By: agate Date: July 22, 2021, 11:15 am |
|
--------------------------------------------------------- |
|
More on this--from PubMed (July 22, 2021)--"Home infusions of |
|
natalizumab for people with multiple sclerosis: A pilot |
|
randomised cross-over trial": |
|
https://pubmed.ncbi.nlm.nih.gov/34288591/ |
|
#Post#: 3362-------------------------------------------------- |
|
Re: At-home Tysabri infusions seem as safe and effective as thos |
|
e at clinics |
|
By: agate Date: July 31, 2021, 1:06 am |
|
--------------------------------------------------------- |
|
This article in Multiple Sclerosis News Today (July 26, 2021) |
|
discusses the study cited in the previous post--"At-home Tysabri |
|
Infusions for RRMS Appear as Safe, Effective as Those at |
|
Cinics": |
|
https://bit.ly/3ldqr6H |
|
#Post#: 3983-------------------------------------------------- |
|
Re: (Abst.) Switching from hospital administration of natalizuma |
|
b to at-home administration |
|
By: agate Date: April 2, 2023, 1:23 am |
|
--------------------------------------------------------- |
|
During the COVID-19 pandemic, for a year this group of |
|
researchers administered natalizumab infusions in the |
|
home for some 30 MS patients. |
|
From PubMed (April 1, 2023)--"Switching from natalizumab |
|
administration at the day hospital to administration at home |
|
...": |
|
https://pubmed.ncbi.nlm.nih.gov/37001411/ |
|
#Post#: 4030-------------------------------------------------- |
|
Re: (Abst.) Risk management in a natalizumab home infusion proce |
|
dure |
|
By: agate Date: May 20, 2023, 1:35 am |
|
--------------------------------------------------------- |
|
From PubMed (May 19, 2023)--"Evaluation of risk management in a |
|
natalizumab home infusion procedure": |
|
https://pubmed.ncbi.nlm.nih.gov/37202259/ |
|
***************************************************** |
